DALLAS, Feb. 16, 2012 (GLOBE NEWSWIRE) -- MicroStockProfit.com announces a stock report featuring BioSante Pharmaceuticals Inc. (Nasdaq:BPAX). The report details the company's most recent developments and news, outlines its financial position and market performance, and includes an easy-to-read stock chart.
MicroStockProfit.com is the premier destination for investment information, making your trading decisions easier than ever. Get the rundown on how BPAX stacks up against its competitors and check-out the stock's technical data by viewing the free, in-depth report for BPAX at: http://www.microstockprofit.com/lp/BPAX
This newsletter has been helping traders make great investment decisions on BPAX; click here for a 15% discount offer.
In the report, the analyst notes:
"Shares of the Lincolnshire, Ill.-based specialty pharmaceutical company got a 61% boost Wednesday following news that the Food and Drug Administration (FDA) had cleared the sale of Bio-T-Gel, the Company's testosterone replacement product for men."
"BPAX posted a net loss of $12.7 million, or $(0.12) per share, for the third quarter of 2011, compared to a net loss of $11.6 million or $(0.16) per share for the third quarter 2010."
To read the entire report visit: www.microstockprofit.com/lp/BPAX
See what investors are saying about BPAX at http://www.stockhideout.com
Get breaking news on BPAX at http://thestockmarketwatch.com/
MicroStockProfit.com is a small-cap research and investment commentary provider. MicroStockProfit.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. Please visit http://www.microstockprofit.com for more information.
MicroStockProfit.com Disclosure
MicroStockProfit.com is not a registered investment advisor; nothing contained in any materials should be construed as a recommendation to buy or sell any securities. MicroStockProfit.com is a Web site wholly owned by BlueWave Advisors, LLC. Neither MicroStockProfit.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. Please read our report and visit our Web site, MicroStockProfit.com, for complete risks and disclosures.